Solutio™ catheter
CAUTION: For investigational use only. The Solutio catheter has not been evaluated by the FDA and is not available for sale in the USA.
Latest news
MedVasc Selected to Present at Prestigious MedTech Pitch Day by HGTF 2025
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
Dr. Michael Åkesson featured on stage at the American Venous Forum, Atlanta
MedVasc Selected to Present at Prestigious MedTech Pitch Day by HGTF 2025
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
Dr. Michael Åkesson featured on stage at the American Venous Forum, Atlanta
Changing the anesthesia procedure
With only one injection, instead of several injections through the skin, the Solutio catheter deploys local anesthesia from inside the vein, making the anesthesia procedure less painful for the patient, and more efficient for the clinician. The technology is developed from a clinical need and our first-in-man proved Solutio to be safe to use while significantly lowering pain in the process of deploying local anesthesia prior to performing thermal ablation of varicose veins. The Solutio catheter is compatible with a vast amount of treatment catheters in the market.
The Solutio catheter
Be the first one to try the Solutio catheter, sign up to get more information.
Based on years of experience
MedVasc AB was founded in 2013 by Michael Åkesson and has during the last years, developed a final prototype, been granted patents and trademarks in all prioritized markets, and performed a first-in-man clinical study. During 2023 MedVasc have initiated the FDA 510k process to gain a regulatory pathway towards FDA clearance.
